MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Movement disorders in children with progressive myoclonic epilepsies

    M. Ben Hafsa, H. Benrhouma, M. Jamoussi, T. Ben Younes, Z. Miladi, A. Zioudi, H. Klaa, I. Kraoua, I. Ben Youssef-Turki (Tunis, Tunisia)

    Objective: To analyze the clinical aspects, radiological features and evolution of myoclonus and other movement disorders (MD) in children with progressive myoclonic epilepsies (PMEs). Background:…
  • 2023 International Congress

    Factors influencing voice function after deep brain stimulation in Parkinson’s disease

    H. Jergas, T. Tsuboi, V. Stopic, D. Nakatsubo, C. Hennen, S. Maesawa, J. Einhaus, R. Saito, V. Visser-Vandewalle, M. Katsuno, M. Barbe (Cologne, Germany)

    Objective: To assess the effect of Deep Brain Stimulation (DBS) on self-perceived changes of voice function in Parkinson’s disease (PD). Background: To date, the effect…
  • 2023 International Congress

    Association between type 2 diabetes mellitus with parkinson’s disease and the increase of the severity of depression and anxiety in a mexican population

    AA. Herrera Ruiz, DR. Aguila Godinez, AJ. Hernández-Medrano, MA. Ruiz Mafud, A. Abundes-Corona, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)

    Objective: To compare the severity of depression and anxiety in PwP between those with T2D and those without T2D. Background: Parkinson's disease (PD) is the…
  • 2023 International Congress

    Nonketotic hyperglycemia-induced hemichorea/hemiballism in El Salvador: A case Series

    R. Lopez-Castellanos, R. Lopez-Contreras (Atlanta, USA)

    Objective: We conducted a retrospective study to investigate the clinical characteristics of patients with nonketotic hyperglycemia-induced hemichorea/hemiballism referred to a movement disorder clinic in El…
  • 2023 International Congress

    Words Spoken Daily: A Novel Measure of Cognition

    S. Lettenberger, M. Zafar, J. Soto, Y. Zhang, G. Zhu, A. Masino, G. Nkrumah, E. Waddell, K. Spear, A. Arky, R. Toor, E. Hartman, J. Epifano, R. Christie, Z. Duan, R. Dorsey (Rochester, USA)

    Objective: To assess the average number of words spoken per day by individuals with Parkinson’s disease (PD), mild cognitive impairment (MCI), and control participants. Background:…
  • 2023 International Congress

    Constipation in Parkinson’s disease, a common problem with rare but serious complications

    S. Lopes, S. Marques, A. Ferreira, S. Varanda, AM. Rodrigues (Braga, Portugal)

    Objective: To report the case of a Parkinson’s disease patient suffering from constipation complicated with a sigmoid volvulus and definitive colostomy Background: Non-motor features of Parkinson's disease…
  • 2023 International Congress

    Comparative Analysis of Stepwise Unilateral and Simultaneous Bilateral Deep Brain Stimulator Electrode Placement for Parkinosn’s Disease

    K. Yekuno, M. Marsans, C. Drolet, J. Roberts, S. Srivastal, F. Farrokhi (Seattle, USA)

    Objective: The goal of this paper is to compare the time required to achieve the maximum possible quality of life (i.e. number of programming visits),…
  • 2023 International Congress

    Differences of social and clinical factors related with distribution of DBS in Mexican PD population

    MF. Medina Pérez, DR. Aguila Godinez, AA. Herrera Ruiz, EC. Santiago Cruz, LG. Lira Juárez, MAG. Medrano Delgado, MA. Ruiz Mafud, AJ. Hernández-Medrano, AY. Regalado Mustafá, DP. Romero-Terán, GI. Cerda Hernández, M. Rodríguez-Violante, A. Cervantes-Arriaga, G. Hernandez Armesto, A. Abundes-Corona, AG. Alcocer-Salas (Mexico, Mexico)

    Objective: To identify which social and clinical factors are related to disparities between the distribution of DBS in Mexican PD population Background: Deep Brain stimulation…
  • 2023 International Congress

    Correlation between dose of dopamine replacement therapy and King’s Parkinson’s Disease Pain Scale in Mexican Patients with Parkinson’s Disease

    A. Regalado Mustafá, D. Aguila Godinez, A. Herrera Ruiz, E. Santiago-de-La-Cruz, L. Lira Juárez, M. Medrano Delgado, M. Ruiz Mafud, A. Hernández-Medrano, D. Romero-Terán, M. Medina-Pérez, G. Cerda Hernández, M. Rodríguez-Violante, A. Cervantes-Arriaga, G. Hernandez Armesto, A. Abundes-Corona, A. Domínguez García, J. García Hernández, A. Alcocer Salas, K. Talavera Lagunas (Mexico City, Mexico)

    Objective: Investigate the relationship between the dose of dopamine replacement therapy (DRT) and pain severity as measured by the King's Parkinson's Disease Pain Scale (KPPS)…
  • 2023 International Congress

    18F-Florzolotau PET imaging of tau pathology in the living brain of patients with corticobasal syndrome

    FT. Liu, JY. Lu, XY. Li, YM. Sun, JJ. Wu, TC. Yen, QH. Zhao, CT. Zuo, J. Wang (Shanghai, China)

    Objective: To analyze the topographical patterns of tau pathology in the living brains of patients with CBS using 18F-Florzolotau PET imaging and to examine whether…
  • « Previous Page
  • 1
  • …
  • 151
  • 152
  • 153
  • 154
  • 155
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley